Northern Illinois shhoter on Psychiatric Drugs including SSRI's

[Guest guest]

-

_Fred Baughman_ (fredbaughmanmd)

_duane baughman_ (dbaughman)

Thursday, February 21, 2008 1:32 PM

SUICIDE & PSYCHIATRIC DRUGS: DUE TO CHEMICAL IMBALANCE OR CHEMICAL

BALANCER--DRUG 2 21 08

 

 

 

WAKE UP AMERICA--ALL DRUGS ARE POISONS

 

(Not “Chemical Balancers†for “Chemical Imbalances†of the Brain)

 

By *Fred A. Baughman Jr., MD Neurologist, Child Neurologist

On CNN, last night, 2/20/08, it was reported that the Northern Illinois

University shooter, Steven P. Kazmierczak had been on Prozac, Ambien and Xanax,

all, apparently, prescribed by the same psychiatrist. The talking head “

forensic psychologist†was quick to point out that homicidal and suicidal

ideation would have to be present in such cases prior to the drug usage, that

they

are not due to the drugs themselves. Evidence that the SSRI antidepressants

and most other psychiatric drugs can precipitate suicidal and homicidal urges

abounds.

On May 15, 2000, The Boston Globe reported (Doctor lashes out in Prozac

battle By Richard A. Knox, Globe Staff): Dr. Jonathan O. Cole, a Harvard

psychiatrist who was one of the first to suggest that Prozac and similar

antidepressants could

precipitate suicide, is now criticizing drug companies and the US

Food and Drug Administration, saying they are failing to take the

problem seriously. Cole made his complaint in support of a federal court

lawsuit

that claims the drug Zoloft, a chemical cousin of Prozac, caused

a 13-year-old Kansas City youth to kill himself. ''I still believe our 1990

article was correct and it does happen,'' Cole said of the alleged

suicide-antidepressant link that he and other McLean Hospital researchers first

suggested a decade

ago. Although Cole had remained silent amid manufacturers' efforts

to discredit his research, the Boston psychiatrist said he was

angered by the actions of Zoloft's maker, Pfizer Inc., in fighting

the lawsuit brought by the family of Matthew Miller, the Missouri

teenager. The youth had been taking Zoloft for only a week when he

hanged himself in his bedroom closet on July 28, 1997.

In December, 1994 Cole (Director, Psychopharmacology Research at the NIMH

and Chairman of the Department of Psychiatry, McLean Hospital)

was interviewed on the very subject by David Healy (published in The

Psychopharmacologists, Chapman & Hall, London, 1996)

Healy: What about a group of patients who may get worse on it (Prozac)?

Cole: Yes. I’m one of the authors of the suicide paper…I didn’t realize

it

would be quite that famous…Yes, I have seen people, at least a handful, that

clearly got more agitated and got weird thoughts and suicidal drive. Rothschild…found three people who had jumped off something while on

fluoxetine, who didn’t kill themselves, and agreed to take it again. He

re-created

the same desparate driven quality with fluoxetine.

Healy: Is it a form of akathesia (inability to remain sitting still due to

with a sense of motor restlessness and a feeling of muscle quivering. Known

to be caused by antipsychotic and other psychiatric drugs) ?

Cole: I think it probably is but whether you get the neuromuscular form or

whether it’s purely psychic I don’t know. One patient…was so distressed

by a

thought telling her to kill herself over and over again, …I told her to take

some Ativan (lorazepam, a benzodiazepam, Valium-like) and go to sleep and she

did and within 36 hours it had passed. At the end of it she said ‘gee, I’

ve been depressed for 21 years, and suicidal a lot but that was ridiculous.’

She thought it was clearly different than anything she had ever experienced

before which is why I put her case and my name on the paper. Lilly

(manufacturer of Prozac) doesn’t believe it…Plus about 1-2% of the people

on

fluoxetine, and none of the people on trazodone (Desyrel, called up and said

I’ve

got suicidal ideas that I haven’t had before and another 1-2% phoned up and

said I’ve got crazy ideas that I hadn’t had before…

Cole: But the company probably did exactly the right thing which was to

stone wall and the FDA didn’t do anything. The company was publishing

meta-analyses of everything in the world - 800 patients in 6-week trials with

no

increase in suicidal ideation…(a tactic, as Cole points out, to deny and

counter

the suicidal ideation being caused by their drug Prozac).

In the Transworld News (Stockholm, Sweden) of January 9, 2008, investigative

journalist Janne Larsson reports that of persons completing suicide more

than 80 percent were on psychiatric drugs with 50% of those having been

antidepressants. Health care providers in Sweden are now required by law to

report

all suicides committed up to four weeks after last health care visit. 367

suicides were reported per this law for 2006. More than 80 percent of persons

committing suicide were “treated†with psychiatric drugs; in well over 50

percent of the cases (of those “treated†with a psychiatric drug or drugs)

the persons got antidepressants, in more than 60 cases neuroleptics

(antipsychotics) or antidepressants.

This information has been concealed by psychiatric officials at the

National Board of Health and Welfare. This blew the myths of antidepressants

and

neuroleptics as suicide-protecting drugs to pieces. It would also have hurt the

career of many medical journalists to take up this subject; journalists who

for years have made their living by writing marketing articles about new

antidepressant drugs. So nothing has been written about this in major media in

Sweden.

Senior officials at the National Board of Health and Welfare have relied on

evaluations from well-known Swedish SSRI (Prozac-like antidepressants

including Paxil, Zoloft, Celexa, Luvox) proponents, (like psychiatrists G.

Isaksson, A.L. von Knorring) who for the last decade have touted the new

antidepressants as “life savingâ€. A senior official said that “evidence

based treatment

of the underlying psychiatric disorder can reduce the risk for suicideâ€,

referring to the “protective effect†that he believed antidepressant drugs

had.

The data about the large percentage of persons committing suicide,

“treatedâ€

with psychiatric drugs, were brushed aside by the official, saying the data “

cannot currently be seen as a representative source for a discussion about

these questions†.

The agency has recently published its first analysis of cases from 2006,

reported per the new law (Suicides 2006, reported per Lex Maria; in Swedish).

Not a single word is written about the most compelling fact: Well over 80

percent of persons killing themselves were treated with psychiatric drugs.

Instead of using this result to save lives the result was hidden.

It was claimed: “Every investigated suicide where one can see flaws that can

be taken care of, can contribute to the prevention of further suicides.†Yet

no investigation at all was done in the suicide inducing effect of

antidepressants and neuroleptics.

At (a) regional level at the agency there are definitely officials wanting

to do a good job and get at the real facts of the scene. They are however

betrayed by top management. For example: The forms ordered to be used at

regional

level when investigating suicide cases completely omit factors about drug

treatment.

A certain number of persons killing themselves can be expected to be

suffering from drug induced akathisia – an extreme inner restlessness, a

feeling of

having to creep out of ones skin, a completely unbearable condition. It is

created by the psychiatric drugs, not by any “underlying diseaseâ€. (Here

again, the claim from within organized psychiatry that emotional and

behavioural

problems and diagnoses are “diseasesâ€/ “chemical imbalances†of the

brain,

needing prescription “chemical balancersâ€â€”drugs) Akathisia is a

condition

that can make a person commit violent acts – against self or others. It is a

condition officially recognized and taken up in the warning texts for the

drugs. A number of persons have been affected by mania or hypomania – again

created by the drugs; conditions also officially recognized; conditions that

can

lead to suicide.

Some of the valid questions in an objective investigation would be: Is the

suicide an effect of an unbearable condition created by the drugs (like

akathisia)? Has the drug dose been increased – with a catastrophic result –

when

the worsened condition in actual fact was caused by the drug (while being

blamed on the “underlying diseaseâ€)? Has the patient been subject to an

abrupt

discontinuation (with severe withdrawal symptoms as the result)? Is the

catastrophic result very likely caused by concomitant use of psychiatric drugs?

Has

the patient been informed about the serious harmful effects that these drugs

can cause?

None of these questions are part of the form worked out by senior officials

at the National Board of Health and Welfare (Sweden).

These questions would – if asked and the answers used – save lives. But

they would also threaten the profits of Big Pharma and the careers of their

hired psychiatrists. Therefore they cannot be asked. Janne Larsson, writer –

investigating psychiatry, Sweden, _janne.olov.larsson@teli_

(janne.olov.larsson)

And what of methamphetamine and the amphetamines where suicide is concerned.

(Meth Use Linked to Teen Suicide, by Fred A. Baughman Jr., MD 8/17/99):

East County Supervisor Dianne Jacob led the drive to establish the

Methamphetamine Strike Force in 1996 (The Daily Californian, 8/17/99). “This

year,

one statistic literally jumped off the page,†Jacob said during a press

conference Monday, “That’s the frightening connection between youth and

methamphetamine use. …about one-third of teen suicides were involved with

methamphetamine. That’s a startling statisticâ€

Officials report that 36% (thirty-six) of suicides among those 8-19 years of

age were directly related to met in 1997. Moreover, for every teen suicide,

20 others are hospitalized after a suicide attempt. And, San Diego police

report that 47% (forty-seven) of juveniles arrested test positive for

methamphetamine—street name, “crystal.â€

Trauma doctor, Michael Sise of Mercy Hospital says they see “an alarming

number of victims of intentional and unintentional—spectacularly violent—

injuries†(San Diego Union-Tribune, 8/17/99) County officials spoke of

the link

they increasingly see between methamphetamine and depression. “The drug is a

powerful, highly addictive one that people take more and more of to get an

effect until they develop almost a pure outright paranoid psychosis,†Sise

said. “That lead to a profound depression lasting weeks to months. JH

Halpern,

MD of the Harvard Medical School recently wrote in the Journal of the

American Medical Association (1999;281:1491): The AMA Council of Scientific

Affairs

[1] reasoned that a review of the treatment and diagnosis of ADHD is of

timely importance, as…there is a public “climate among physicians, parents,

and

educators†about treatment with psychostimulants, despite the clear efficacy

these medications offer. It is, for this reason, surprising to find that the

authors failed to mention that methamphetamine is also a US Food and Drug

Administration-approved treatment for ADHD. No data exist that prescribed

methamphetamine is more likely to be abused than methylphenidate (Ritalin,

Concerta) or d-amphetamine (Dexedrine). …With the longest duration of action

of any

of the stimulants (8-12 hours), methamphetamine (trade names: Gradumet,

Desoxyn, indication: “Treatment of attention-deficit disorder with

hyperactivity,

ADHD) has the advantage of offering true once-a-day dosing. In addition,

methamphetamine still has a limited role in the treatment of obesity, has

antidepressant properties [3], and is an effective treatment for narcolepsy

[4].

Do the “pushers†wear white?

Testifying before the 1970 House of Representatives hearing on funding

pharmacological research and therapy for school problems (the first at which

hyperkinesis (hyperkinetic disorder—HKD) was represented to be a medical

disease),

Dr John D. Griffith, Assistant Professor of Psychiatry, Vanderbilt

University School of Medicine. –“I would like to point out that every drug,

however

innocuous, has some degree of toxicity. A drug, therefore, is a type of poison

and its poisonous qualities must be carefully weighed against its

therapeutic usefulness. A problem, now being considered in most of the

Capitols of

the Free World, is whether the benefits derived from Amphetamines outweigh

their toxicity. It is the consensus of the World Scientific Literature that

the

Amphetamines are of very little benefit to mankind. They are, however, quite

toxic. …after many years of clinical trials it is now evident that this

antidepressant effect of Amphetamines is very brief- on the order of days. If

a patient attempts to overcome this tolerance to the drug, he runs the risk

of becoming addicted and even more depressed†–and, as with methamphetamine

(with all amphetamines) —suicidal.

Friend, ally, Ron Thompson, wrote of a 9/6/07 headline in the Washington

Post:

Suicides Rise as Prescription Use Declined - with the insidious and

accusatory

subtitle, Child Antidepressant Warnings Coincided With Increase (suggesting

that as warning of suicidality related to antidepressants increased, and use

of such drugs dropped, the rate of child suicides increase). Ron continued:

 

Which title more accurately reflects what your article actually says? But

NO, first you let yourself spin the story in a way that protects the undeserved

medical legitimacy of " biological " psychiatry for the first two-thirds of

the story (5 columns out of 7), dominated by the supposed fact that an

additional 3,040 people are dead because

of an irresponsible action by the FDA (black box warning of suicidality on

SSRI inserts). Only after this profound and disturbing assertion has been

fully explored

do you then report the stunning rebuttal of David Healy that what

is actually going on is not Anti-Depressants vs. No Treatment (the clear

implication of the first two-thirds of the story), but Anti-Depressants vs.

Anti-Psychotics - which are even more painful to take, and have a longer

list of more serious side-effects, including irreversible diabetes. Dr

Healy's statement, if true, should have been the OPERATIVE FACT of the story

and

reflected in the story's title. But even after you finally get to the key

fact, you then give the

political psychiatrist who heads NIMH the opportunity to ignore this fact -

this allegation

and to let him reframe the story without responding to Healy, by

dismissively saying that the supposed " subset " of patients whose suicide

might be triggered by anti-depressants in 1/10th of 1%. Which FACT would have

been easier for a responsible reporter to check, Shankar (Shankar Vedatam,

Washington Post reporter on things psychiatric),

that of the massive substitution of one set of drugs for another, or the

percentage tossed off by Insel (Thomas Insel, the “political†psychiatrist

now director of the National Institute of Mental Health) ? Which,

interestingly, operates to mitigate the importance of the death of the 3,040

mentioned

earlier. Psychiatry gets to have it both ways, thanks to how you mishandled

the information. - in the early part of the story, the deaths are horrible

because of the lack of use of psychiatric drugs (which later turns out not to

be

true, in fact) And then the deaths are unimportant because of the (supposed)

beneficial effects of the drugs in 99.1% of cases. Really neat! How hard

would it have been for you to ask all the people you interviewed if most

patients

(young people) on anti-depressants in fact have been switched by their

doctors to anti-psychotics? Once again, you've been had. And the Public has

been

cheated of the full and most probably the real story. This is what happens

when a reporter's mind has been subverted by

ideology, and he's become incapable of skepticism toward the assertions of

those he

trusts too much and too uncritically. Ron Thompson

And now, Ron, we have the antipsychotics/neuroleptics as yet another class

of psychiatric drug driving people to kill themselves. Ron, has Shankar been

swayed by ideology or with the usual tender of big pharma—cash? What else

explains the lock-step complicity of the US press that you and I know to be a

matter of fact.

This has been a hurried review of the suicidality and homicidality in

psychiatry always said by the psycho-pharmaceutical cartel to be due to one or

more

psychiatric “disease†or “chemical imbalance†of the brain. Be warned

before taking that first, fifth or tenth “chemical balancerâ€â€”pill, that

there

is no such thing as psychiatric “diseases†or “chemical imbalance†of

the

brain, there is only your still-normal brain generating still-normal emotions,

positive and negative, serving as a barometer as to how you are coping with

life and it’s challenges. Pop that first prescription “chemical

balancerâ€

and your brain and ability to know how you stand at the game of life and how

to adapt to how and where you stand will no longer be normal, no longer

unimpaired. The physical “you†and your normal brain, your ultimate tool

of

adaptation, will no longer be normal. Think of this long and hard before

succumbing to the lure of a pain-free existence, that sold by licit and illicit

drug

dealers alike.

Think of the fact that the FDA, now a disgraceful, wholly-owned & operated

subsidiary of Big Pharma pretends to protect us by requiring clinical trials

of no more than a few weeks to 2-3 months at most, and based upon these they

conclude that nearly every new chemical they are handed is “safe and

effectiveâ€

–another breakthrough. Essentially, there is no such thing in the US today

as knowing anything about the long-range effects, positive or negative, of

each new drug that comes along. What’s more the voluntary, FDA MedWatch

scheme by which side effects are reported is kept voluntary because that is the

way that Big Pharma wants it. Then don’t what to know if there are more

heart

attacks, strokes and suicides and they don’t want it known and, for this

reason MedWatch continues to rely wholly and solely on side-effect reports that

are voluntary, never required, never an indication of the damage being done to

us in the name to “treatment†by Big Pharma and the medical instrumentation

industry as well.

Since circa 1960 when Frances Kelsey of the FDA stood firm and protected the

US populace from the marketing of thalidomide by blocking it from market,

the FDA has fallen into the slime. Those who think it tests, and probes and

really protects, delude themselves and are at this much and more risk.

We owe Janne Larsson, Ron Thompson and the Brit, David Healy, each a salute

for trying to do what our FDA no longer does—protect us from the legal,

licit drug profiteers who get away with horrendous crimes on a daily basis.

(http://psychrights.org/Articles/SwedishSuicides.htm)

(http://psychrights.org/Articles/SwedishSuicides.htm)

 

The polypharmacy in Kaczmierczac case—3 drugs at one time--underscores the

rise of polypharmacy in psychiatric treatment—more dangerous and less

scientific and comprehensible with each drug added—none of them, not even the

first

drug, addressing a defined abnormality/disease/chemical imbalance.

 

*Fred Baughman, MD, Neurologist, Child Neurologist

Author:

 

1. THE ADHD FRAUD

2. EL FRAUDE DEL TDAH (same book in Spanish)

www. Trafford.com

 

 

 

 

 

 

**************Ideas to please picky eaters. Watch video on AOL Living.

(http://living.aol.com/video/how-to-please-your-picky-eater/rachel-campos-duffy/

2050827?NCID=aolcmp00300000002598)

 

 

 

[Guest guest]

It was about time that someone tells what is going on with

psychofarmac drugs.

Thank you for this revealing article!

Orlando

 

 

, arnoldgore

wrote:

>

>

>

>

> -

> _Fred Baughman_ (fredbaughmanmd)

> _duane baughman_ (dbaughman)

> Thursday, February 21, 2008 1:32 PM

> SUICIDE & PSYCHIATRIC DRUGS: DUE TO CHEMICAL IMBALANCE OR

CHEMICAL

> BALANCER--DRUG 2 21 08

>

>

>

> WAKE UP AMERICA--ALL DRUGS ARE POISONS

>

> (Not “Chemical Balancers†& #65533; for “Chemical Imbalances†& #65533; of

the

Brain)

>

> By *Fred A. Baughman Jr., MD Neurologist, Child Neurologist

> On CNN, last night, 2/20/08, it was reported that the Northern

Illinois

> University shooter, Steven P. Kazmierczak had been on Prozac,

Ambien and Xanax,

> all, apparently, prescribed by the same psychiatrist. The talking

head “

> forensic psychologist†& #65533; was quick to point out that homicidal and

suicidal

> ideation would have to be present in such cases prior to the drug

usage, that they

> are not due to the drugs themselves. Evidence that the SSRI

antidepressants

> and most other psychiatric drugs can precipitate suicidal and

homicidal urges

> abounds.

> On May 15, 2000, The Boston Globe reported (Doctor lashes out in

Prozac

> battle By Richard A. Knox, Globe Staff): Dr. Jonathan O. Cole, a

Harvard

> psychiatrist who was one of the first to suggest that Prozac and

similar

> antidepressants could

> precipitate suicide, is now criticizing drug companies and the US

> Food and Drug Administration, saying they are failing to take the

> problem seriously. Cole made his complaint in support of a

federal court

> lawsuit

> that claims the drug Zoloft, a chemical cousin of Prozac, caused

> a 13-year-old Kansas City youth to kill himself. ''I still believe

our 1990

> article was correct and it does happen,'' Cole said of the alleged

> suicide-antidepressant link that he and other McLean Hospital

researchers first

> suggested a decade

> ago. Although Cole had remained silent amid manufacturers'

efforts

> to discredit his research, the Boston psychiatrist said he was

> angered by the actions of Zoloft's maker, Pfizer Inc., in

fighting

> the lawsuit brought by the family of Matthew Miller, the Missouri

> teenager. The youth had been taking Zoloft for only a week when

he

> hanged himself in his bedroom closet on July 28, 1997.

> In December, 1994 Cole (Director, Psychopharmacology Research at

the NIMH

> and Chairman of the Department of Psychiatry, McLean Hospital)

> was interviewed on the very subject by David Healy (published in

The

> Psychopharmacologists, Chapman & Hall, London, 1996)

> Healy: What about a group of patients who may get worse on it

(Prozac)?

> Cole: Yes. I’m one of the authors of the suicide paper…I

didn’t realize it

> would be quite that famous…Yes, I have seen people, at least a

handful, that

> clearly got more agitated and got weird thoughts and suicidal

drive. > Rothschild…found three people who had jumped off something while

on

> fluoxetine, who didn’t kill themselves, and agreed to take it

again. He re-created

> the same desparate driven quality with fluoxetine.

> Healy: Is it a form of akathesia (inability to remain sitting

still due to

> with a sense of motor restlessness and a feeling of muscle

quivering. Known

> to be caused by antipsychotic and other psychiatric drugs) ?

> Cole: I think it probably is but whether you get the neuromuscular

form or

> whether it’s purely psychic I don’t know. One patient…was so

distressed by a

> thought telling her to kill herself over and over again, …I told

her to take

> some Ativan (lorazepam, a benzodiazepam, Valium-like) and go to

sleep and she

> did and within 36 hours it had passed. At the end of it she said

‘gee, I’

> ve been depressed for 21 years, and suicidal a lot but that was

ridiculous.’

> She thought it was clearly different than anything she had ever

experienced

> before which is why I put her case and my name on the paper.

Lilly

> (manufacturer of Prozac) doesn’t believe it…Plus about 1-2% of

the people on

> fluoxetine, and none of the people on trazodone (Desyrel, called

up and said I’ve

> got suicidal ideas that I haven’t had before and another 1-2%

phoned up and

> said I’ve got crazy ideas that I hadn’t had before…

> Cole: But the company probably did exactly the right thing which

was to

> stone wall and the FDA didn’t do anything. The company was

publishing

> meta-analyses of everything in the world - 800 patients in 6-week

trials with no

> increase in suicidal ideation…(a tactic, as Cole points out, to

deny and counter

> the suicidal ideation being caused by their drug Prozac).

> In the Transworld News (Stockholm, Sweden) of January 9, 2008,

investigative

> journalist Janne Larsson reports that of persons completing

suicide more

> than 80 percent were on psychiatric drugs with 50% of those having

been

> antidepressants. Health care providers in Sweden are now required

by law to report

> all suicides committed up to four weeks after last health care

visit. 367

> suicides were reported per this law for 2006. More than 80

percent of persons

> committing suicide were “treated†& #65533; with psychiatric drugs; in

well over 50

> percent of the cases (of those “treated†& #65533; with a psychiatric

drug or drugs)

> the persons got antidepressants, in more than 60 cases

neuroleptics

> (antipsychotics) or antidepressants.

> This information has been concealed by psychiatric officials at

the

> National Board of Health and Welfare. This blew the myths of

antidepressants and

> neuroleptics as suicide-protecting drugs to pieces. It would also

have hurt the

> career of many medical journalists to take up this subject;

journalists who

> for years have made their living by writing marketing articles

about new

> antidepressant drugs. So nothing has been written about this in

major media in

> Sweden.

> Senior officials at the National Board of Health and Welfare have

relied on

> evaluations from well-known Swedish SSRI (Prozac-like

antidepressants

> including Paxil, Zoloft, Celexa, Luvox) proponents, (like

psychiatrists G.

> Isaksson, A.L. von Knorring) who for the last decade have touted

the new

> antidepressants as “life saving†& #65533;. A senior official said that

“evidence based treatment

> of the underlying psychiatric disorder can reduce the risk for

suicide†& #65533;,

> referring to the “protective effect†& #65533; that he believed

antidepressant drugs had.

> The data about the large percentage of persons committing suicide,

“treated†& #65533;

> with psychiatric drugs, were brushed aside by the official, saying

the data “

> cannot currently be seen as a representative source for a

discussion about

> these questions†& #65533; .

> The agency has recently published its first analysis of cases from

2006,

> reported per the new law (Suicides 2006, reported per Lex Maria;

in Swedish).

> Not a single word is written about the most compelling fact: Well

over 80

> percent of persons killing themselves were treated with

psychiatric drugs.

> Instead of using this result to save lives the result was hidden.

> It was claimed: “Every investigated suicide where one can see

flaws that can

> be taken care of, can contribute to the prevention of further

suicides.†& #65533; Yet

> no investigation at all was done in the suicide inducing effect

of

> antidepressants and neuroleptics.

> At (a) regional level at the agency there are definitely officials

wanting

> to do a good job and get at the real facts of the scene. They are

however

> betrayed by top management. For example: The forms ordered to be

used at regional

> level when investigating suicide cases completely omit factors

about drug

> treatment.

> A certain number of persons killing themselves can be expected to

be

> suffering from drug induced akathisia †" an extreme inner

restlessness, a feeling of

> having to creep out of ones skin, a completely unbearable

condition. It is

> created by the psychiatric drugs, not by any “underlying

disease†& #65533;. (Here

> again, the claim from within organized psychiatry that emotional

and behavioural

> problems and diagnoses are “diseases†& #65533;/ “chemical

imbalances†& #65533; of the brain,

> needing prescription “chemical balancers†& #65533;†" drugs) Akathisia

is a condition

> that can make a person commit violent acts †" against self or

others. It is a

> condition officially recognized and taken up in the warning texts

for the

> drugs. A number of persons have been affected by mania or

hypomania †" again

> created by the drugs; conditions also officially recognized;

conditions that can

> lead to suicide.

> Some of the valid questions in an objective investigation would

be: Is the

> suicide an effect of an unbearable condition created by the drugs

(like

> akathisia)? Has the drug dose been increased †" with a

catastrophic result †" when

> the worsened condition in actual fact was caused by the drug

(while being

> blamed on the “underlying disease†& #65533;)? Has the patient been

subject to an abrupt

> discontinuation (with severe withdrawal symptoms as the result)?

Is the

> catastrophic result very likely caused by concomitant use of

psychiatric drugs? Has

> the patient been informed about the serious harmful effects that

these drugs

> can cause?

> None of these questions are part of the form worked out by senior

officials

> at the National Board of Health and Welfare (Sweden).

> These questions would †" if asked and the answers used †" save

lives. But

> they would also threaten the profits of Big Pharma and the careers

of their

> hired psychiatrists. Therefore they cannot be asked. Janne

Larsson, writer †"

> investigating psychiatry, Sweden, _janne.olov.larsson@teli_

> (janne.olov.larsson)

> And what of methamphetamine and the amphetamines where suicide is

concerned.

> (Meth Use Linked to Teen Suicide, by Fred A. Baughman Jr., MD 8/

17/99):

> East County Supervisor Dianne Jacob led the drive to establish the

> Methamphetamine Strike Force in 1996 (The Daily Californian, 8/17/

99). “This year,

> one statistic literally jumped off the page,†& #65533; Jacob said during

a press

> conference Monday, “That’s the frightening connection between

youth and

> methamphetamine use. …about one-third of teen suicides were

involved with

> methamphetamine. That’s a startling statistic†& #65533;

> Officials report that 36% (thirty-six) of suicides among those 8-

19 years of

> age were directly related to met in 1997. Moreover, for every teen

suicide,

> 20 others are hospitalized after a suicide attempt. And, San

Diego police

> report that 47% (forty-seven) of juveniles arrested test positive

for

> methamphetamine†" street name, “crystal.†& #65533;

> Trauma doctor, Michael Sise of Mercy Hospital says they see “an

alarming

> number of victims of intentional and unintentional†" spectacularly

violent†"

> injuries†& #65533; (San Diego Union-Tribune, 8/17/99) County officials

spoke of the link

> they increasingly see between methamphetamine and depression.

“The drug is a

> powerful, highly addictive one that people take more and more of

to get an

> effect until they develop almost a pure outright paranoid

psychosis,†& #65533; Sise

> said. “That lead to a profound depression lasting weeks to

months. JH Halpern,

> MD of the Harvard Medical School recently wrote in the Journal of

the

> American Medical Association (1999;281:1491): The AMA Council of

Scientific Affairs

> [1] reasoned that a review of the treatment and diagnosis of ADHD

is of

> timely importance, as…there is a public “climate among

physicians, parents, and

> educators†& #65533; about treatment with psychostimulants, despite the

clear efficacy

> these medications offer. It is, for this reason, surprising to

find that the

> authors failed to mention that methamphetamine is also a US Food

and Drug

> Administration-approved treatment for ADHD. No data exist that

prescribed

> methamphetamine is more likely to be abused than methylphenidate

(Ritalin,

> Concerta) or d-amphetamine (Dexedrine). …With the longest

duration of action of any

> of the stimulants (8-12 hours), methamphetamine (trade names:

Gradumet,

> Desoxyn, indication: “Treatment of attention-deficit disorder

with hyperactivity,

> ADHD) has the advantage of offering true once-a-day dosing. In

addition,

> methamphetamine still has a limited role in the treatment of

obesity, has

> antidepressant properties [3], and is an effective treatment for

narcolepsy [4].

> Do the “pushers†& #65533; wear white?

> Testifying before the 1970 House of Representatives hearing on

funding

> pharmacological research and therapy for school problems (the

first at which

> hyperkinesis (hyperkinetic disorder†" HKD) was represented to be a

medical disease),

> Dr John D. Griffith, Assistant Professor of Psychiatry, Vanderbilt

> University School of Medicine. †" “I would like to point out

that every drug, however

> innocuous, has some degree of toxicity. A drug, therefore, is a

type of poison

> and its poisonous qualities must be carefully weighed against its

> therapeutic usefulness. A problem, now being considered in most

of the Capitols of

> the Free World, is whether the benefits derived from Amphetamines

outweigh

> their toxicity. It is the consensus of the World Scientific

Literature that the

> Amphetamines are of very little benefit to mankind. They are,

however, quite

> toxic. …after many years of clinical trials it is now evident

that this

> antidepressant effect of Amphetamines is very brief- on the order

of days. If

> a patient attempts to overcome this tolerance to the drug, he runs

the risk

> of becoming addicted and even more depressed†& #65533; †" and, as with

methamphetamine

> (with all amphetamines) †" suicidal.

> Friend, ally, Ron Thompson, wrote of a 9/6/07 headline in the

Washington

> Post:

> Suicides Rise as Prescription Use Declined - with the insidious

and

> accusatory

> subtitle, Child Antidepressant Warnings Coincided With Increase

(suggesting

> that as warning of suicidality related to antidepressants

increased, and use

> of such drugs dropped, the rate of child suicides increase). Ron

continued:

>

> Which title more accurately reflects what your article actually

says? But

> NO, first you let yourself spin the story in a way that protects

the undeserved

> medical legitimacy of " biological " psychiatry for the first two-

thirds of

> the story (5 columns out of 7), dominated by the supposed fact

that an

> additional 3,040 people are dead because

> of an irresponsible action by the FDA (black box warning of

suicidality on

> SSRI inserts). Only after this profound and disturbing assertion

has been

> fully explored

> do you then report the stunning rebuttal of David Healy that what

> is actually going on is not Anti-Depressants vs. No Treatment (the

clear

> implication of the first two-thirds of the story), but Anti-

Depressants vs.

> Anti-Psychotics - which are even more painful to take, and have a

longer

> list of more serious side-effects, including irreversible

diabetes. Dr

> Healy's statement, if true, should have been the OPERATIVE FACT of

the story and

> reflected in the story's title. But even after you finally get

to the key

> fact, you then give the

> political psychiatrist who heads NIMH the opportunity to ignore

this fact -

> this allegation

> and to let him reframe the story without responding to Healy, by

> dismissively saying that the supposed " subset " of patients whose

suicide

> might be triggered by anti-depressants in 1/10th of 1%. Which

FACT would have

> been easier for a responsible reporter to check, Shankar (Shankar

Vedatam,

> Washington Post reporter on things psychiatric),

> that of the massive substitution of one set of drugs for another,

or the

> percentage tossed off by Insel (Thomas Insel, the “political†& #65533;

psychiatrist

> now director of the National Institute of Mental Health) ? Which,

> interestingly, operates to mitigate the importance of the death of

the 3,040 mentioned

> earlier. Psychiatry gets to have it both ways, thanks to how you

mishandled

> the information. - in the early part of the story, the deaths are

horrible

> because of the lack of use of psychiatric drugs (which later turns

out not to be

> true, in fact) And then the deaths are unimportant because of the

(supposed)

> beneficial effects of the drugs in 99.1% of cases. Really neat!

How hard

> would it have been for you to ask all the people you interviewed

if most patients

> (young people) on anti-depressants in fact have been switched by

their

> doctors to anti-psychotics? Once again, you've been had. And the

Public has been

> cheated of the full and most probably the real story. This is

what happens

> when a reporter's mind has been subverted by

> ideology, and he's become incapable of skepticism toward the

assertions of

> those he

> trusts too much and too uncritically. Ron Thompson

> And now, Ron, we have the antipsychotics/neuroleptics as yet

another class

> of psychiatric drug driving people to kill themselves. Ron, has

Shankar been

> swayed by ideology or with the usual tender of big pharma†" cash?

What else

> explains the lock-step complicity of the US press that you and I

know to be a

> matter of fact.

> This has been a hurried review of the suicidality and homicidality

in

> psychiatry always said by the psycho-pharmaceutical cartel to be

due to one or more

> psychiatric “disease†& #65533; or “chemical imbalance†& #65533; of the

brain. Be warned

> before taking that first, fifth or tenth “chemical

balancer†& #65533;†" pill, that there

> is no such thing as psychiatric “diseases†& #65533; or “chemical

imbalance†& #65533; of the

> brain, there is only your still-normal brain generating still-

normal emotions,

> positive and negative, serving as a barometer as to how you are

coping with

> life and it’s challenges. Pop that first prescription

“chemical balancer†& #65533;

> and your brain and ability to know how you stand at the game of

life and how

> to adapt to how and where you stand will no longer be normal, no

longer

> unimpaired. The physical “you†& #65533; and your normal brain, your

ultimate tool of

> adaptation, will no longer be normal. Think of this long and hard

before

> succumbing to the lure of a pain-free existence, that sold by

licit and illicit drug

> dealers alike.

> Think of the fact that the FDA, now a disgraceful, wholly-owned &

operated

> subsidiary of Big Pharma pretends to protect us by requiring

clinical trials

> of no more than a few weeks to 2-3 months at most, and based upon

these they

> conclude that nearly every new chemical they are handed is “safe

and effective†& #65533;

> †" another breakthrough. Essentially, there is no such thing in

the US today

> as knowing anything about the long-range effects, positive or

negative, of

> each new drug that comes along. What’s more the voluntary, FDA

MedWatch

> scheme by which side effects are reported is kept voluntary

because that is the

> way that Big Pharma wants it. Then don’t what to know if there

are more heart

> attacks, strokes and suicides and they don’t want it known and,

for this

> reason MedWatch continues to rely wholly and solely on side-effect

reports that

> are voluntary, never required, never an indication of the damage

being done to

> us in the name to “treatment†& #65533; by Big Pharma and the medical

instrumentation

> industry as well.

> Since circa 1960 when Frances Kelsey of the FDA stood firm and

protected the

> US populace from the marketing of thalidomide by blocking it from

market,

> the FDA has fallen into the slime. Those who think it tests, and

probes and

> really protects, delude themselves and are at this much and more

risk.

> We owe Janne Larsson, Ron Thompson and the Brit, David Healy, each

a salute

> for trying to do what our FDA no longer does†" protect us from

the legal,

> licit drug profiteers who get away with horrendous crimes on a

daily basis.

> (http://psychrights.org/Articles/SwedishSuicides.htm)

> (http://psychrights.org/Articles/SwedishSuicides.htm)

>

> The polypharmacy in Kaczmierczac case†" 3 drugs at one time--

underscores the

> rise of polypharmacy in psychiatric treatment†" more dangerous and

less

> scientific and comprehensible with each drug added†" none of them,

not even the first

> drug, addressing a defined abnormality/disease/chemical

imbalance.

>

> *Fred Baughman, MD, Neurologist, Child Neurologist

> Author:

>

> 1. THE ADHD FRAUD

> 2. EL FRAUDE DEL TDAH (same book in Spanish)

> www. Trafford.com

**************Ideas to please picky eaters. Watch video on AOL

Living.

> (http://living.aol.com/video/how-to-please-your-picky-eater/rachel-

campos-duffy/

> 2050827?NCID=aolcmp00300000002598)

>

>

>